The selected newsroom has been added to your list of favorites. Go to My Favorites

Our News on Newswise

Newswise: ZoomphotoNatureMedicine.png

Study reveals factors influencing outcomes in advanced kidney cancer treated with immunotherapy

By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune...
28-May-2020 11:05 AM EDT Add to Favorites

Newswise: MaryCooley.jpg

Phyllis F. Cantor Center for Research in Nursing and Patient Care Services awarded two major research grants

Nurse-scientists from the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute received more than $1.3 million dollars in funding for two separate research projects.
26-May-2020 2:20 PM EDT Add to Favorites

Dana-Farber to test blood cancer drug in COVID-19 patients

Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus.
19-May-2020 8:00 AM EDT Add to Favorites

Immune system changes occur early in development of multiple myeloma, study finds

Long before multiple myeloma becomes a malignant disease, the collection of immune system cells and signal carriers amid the tumor cells undergoes dramatic shifts, with alterations in both the number and type of immune cells, researchers at...
24-Apr-2020 3:05 PM EDT Add to Favorites

Newswise: SOG_8576_20.jpg

Dana-Farber Cancer Institute faculty recognized as 2020 ASCO leaders in cancer research and care

The American Society of Clinical Oncology (ASCO) recognized four Dana-Farber Cancer Institute researchers as winners of ASCO's Special Awards, the Society’s highest honors. The recipients of these awards have worked to transform cancer care...
24-Apr-2020 4:25 PM EDT Add to Favorites

New targeted agent produces considerable responses in trial with patients with uterine serous carcinoma

The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial. Data will be shared virtually at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer.
21-Apr-2020 2:30 PM EDT Add to Favorites

SHE Center at Dana-Farber and Silverberry Genomix form SHE Biobank, a Population Health Initiative for Research and Education

Dana-Farber and Silverberry Genomix launch the SHE Biobank initiative -- a long-term study to investigate the impact of genetic predisposition and environmental exposure to development of disease.
23-Apr-2020 2:05 PM EDT Add to Favorites

Newswise: Keith_Ligon_SOG_5449_14.jpg

Massive study reveals how “hypermutated” malignant brain tumors with many mutations escape chemotherapy and immunotherapy

An analysis of more than 10,000 gliomas and clinical outcomes reported in Nature by scientists in Boston and Paris found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.
15-Apr-2020 1:55 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

Newswise: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

See All Experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Contacts

Ellen Berlin
Media Relations Director

ellen_berlin@dfci.harvard.edu

617-632-5357

Robert Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Marlena Baldacci
National Media Relations Manager

marlena_Baldacci@dfci.harvard.edu

857-215-1204

Peter Cohenno
Senior Media Relations Specialist

Peter_Cohenno@dfci.harvard.edu

Claire Monaghan
Senior Media Relations Specialist
hematology

Claire_Monaghan@dfci.harvard.edu

617-632-5653

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Quincey Spagnoletti
Media Relations Specialist

quinceym_spagnoletti@dfci.harvard.edu

315-720-2715

Victoria Warren
Media Relations Manager

Victoria_Warren@dfci.harvard.edu

617-582-9323

Twitter

close
1.93973